VIP and PACAP receptor pharmacology: A comparison of intracellular signaling pathways

Annals of the New York Academy of Sciences

Volumn 1070, Issue , 2006, Pages 239-242

  Dickson, Louise ^a   Aramori, Ichiro ^b   Sharkey, John ^a   Finlayson, Keith ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

CHO K1; GPCR; hPAC 1R; hVPAC1R; hVPAC2R; PACAP; R3P65; VIP; Ala11,22,28 VIP, cAMP i, Ca2+ i

Indexed keywords

CALCIUM ION; CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; PROTEIN DERIVATIVE; R3P65 PROTEIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ASSAY; CELL LINE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENCY; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 33746388326     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1317.021     Document Type: Conference Paper

References (4)

1. HARMAR, A.J. 2001. Family-B G-protein-coupled receptors. Genome Biol. 2: 3013.1-3013.10.
2. MCCULLOCH, D.A. et al. 2002. Additional signals from VPAC/PAC family receptors. Biochem. Soc. Trans. 30: 441-446.
3. NICOLE, P. et al. 2000. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide. J. Biol. Chem. 275: 24003-24012.
4. YUNG, S.L. et al. 2003. Generation of highly selective VPAC2 receptor agonists by high throughput mutagenesis of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide. J. Biol. Chem. 278: 10273-10281.